Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Other Accumulated Expenses (2022 - 2025)

Standard Biotools (LAB) has disclosed Other Accumulated Expenses for 4 consecutive years, with $3.6 million as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses fell 23.06% to $3.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Dec 2025, down 23.06% year-over-year, with the annual reading at $3.6 million for FY2025, 23.06% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $3.6 million at Standard Biotools, up from $2.5 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $7.3 million in Q3 2024, with the low at $714000.0 in Q3 2023.
  • Average Other Accumulated Expenses over 4 years is $3.9 million, with a median of $4.0 million recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses skyrocketed 917.51% in 2024, then tumbled 83.63% in 2025.
  • Over 4 years, Other Accumulated Expenses stood at $913000.0 in 2022, then skyrocketed by 341.73% to $4.0 million in 2023, then rose by 15.5% to $4.7 million in 2024, then fell by 23.06% to $3.6 million in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $3.6 million, $2.5 million, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.